Products

Porcine reproductive and respiratory syndrome virus cDNA and Antigen

Cat#	Product Name	Swiss Prot#	Size	Price (US$)	Order
PN1322	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Major envelope glycoprotein (a.a.21 to 144)	A0SG62	100 µg	1195	Order
PN1323	Recombinant Protein-Porcine reproductive and respiratory syndrome virus GP3 envelope protein (a.a.31 to 254)	A1YZP5	100 µg	1195	Order
PN1324	Recombinant Protein-Porcine reproductive and respiratory syndrome virus GP5 envelope protein (a.a.35 to 200)	A1YZP6	100 µg	1195	Order
PN1325	Recombinant Protein-Porcine reproductive and respiratory syndrome virus GP4 envelope protein (a.a.21 to 178)	A1YZQ1	100 µg	1195	Order
PN1326	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Nucleocapsid (a.a.18 to 123)	B1NE29	100 µg	1195	Order
PN1327	Recombinant Protein-Porcine reproductive and respiratory syndrome virus GP3 envelope protein (a.a.31 to 254)	A1YZP5	100 µg	1195	Order
PN1328	Recombinant Protein-Porcine reproductive and respiratory syndrome virus GP2 (a.a.41 to 256)	A1YZP9	100 µg	1195	Order
PN1329	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Matrix protein (a.a.31 to 174)	B1PI37	100 µg	1195	Order
PN1330	Recombinant Protein-Porcine reproductive and respiratory syndrome virus N protein (a.a.19 to 107)	B3VI54	100 µg	1195	Order
PN1331	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Major envelope glycoprotein GP5 (a.a.35 to 201)	B9TR02	100 µg	1195	Order
PN1332	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Nucleocapsid protein (a.a.19 to 130)	Q1A4Y4	100 µg	1195	Order
PN1333	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Glycosylated envelope protein GP5 (a.a.33 to 201)	Q8JYG0	100 µg	1195	Order
PN1334	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Envelope glycoprotein (a.a.42 to 265)	Q9PZ86	100 µg	1195	Order
PN1335	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Non-structural protein 3 (a.a.1579 to 1809)	Q9YN02	100 µg	1195	Order
PN1336	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Non-structural protein 11 (a.a.3591 to 3813)	Q9YN02	100 µg	1195	Order
PN1337	Recombinant Protein-Porcine reproductive and respiratory syndrome virus Non-structural protein 12 (a.a.3814 to 3966)	Q9YN02	100 µg	1195	Order
RPN1322	cDNA-Porcine reproductive and respiratory syndrome virus Major envelope glycoprotein (a.a.21 to 144)	A0SG62	2 µg	800	Order
RPN1323	cDNA-Porcine reproductive and respiratory syndrome virus GP3 envelope protein (a.a.31 to 254)	A1YZP5	2 µg	1115	Order
RPN1324	cDNA-Porcine reproductive and respiratory syndrome virus GP5 envelope protein (a.a.35 to 200)	A1YZP6	2 µg	825	Order
RPN1325	cDNA-Porcine reproductive and respiratory syndrome virus GP4 envelope protein (a.a.21 to 178)	A1YZQ1	2 µg	785	Order
RPN1326	cDNA-Porcine reproductive and respiratory syndrome virus Nucleocapsid (a.a.18 to 123)	B1NE29	2 µg	800	Order
RPN1327	cDNA-Porcine reproductive and respiratory syndrome virus GP3 envelope protein (a.a.31 to 254)	A1YZP5	2 µg	1115	Order
RPN1328	cDNA-Porcine reproductive and respiratory syndrome virus GP2 (a.a.41 to 256)	A1YZP9	2 µg	1075	Order
RPN1329	cDNA-Porcine reproductive and respiratory syndrome virus Matrix protein (a.a.31 to 174)	B1PI37	2 µg	715	Order
RPN1330	cDNA-Porcine reproductive and respiratory syndrome virus N protein (a.a.19 to 107)	B3VI54	2 µg	800	Order
RPN1331	cDNA-Porcine reproductive and respiratory syndrome virus Major envelope glycoprotein GP5 (a.a.35 to 201)	B9TR02	2 µg	830	Order
RPN1332	cDNA-Porcine reproductive and respiratory syndrome virus Nucleocapsid protein (a.a.19 to 130)	Q1A4Y4	2 µg	800	Order
RPN1333	cDNA-Porcine reproductive and respiratory syndrome virus Glycosylated envelope protein GP5 (a.a.33 to 201)	Q8JYG0	2 µg	840	Order
RPN1334	cDNA-Porcine reproductive and respiratory syndrome virus Envelope glycoprotein (a.a.42 to 265)	Q9PZ86	2 µg	1115	Order
RPN1335	cDNA-Porcine reproductive and respiratory syndrome virus Non-structural protein 3 (a.a.1579 to 1809)	Q9YN02	2 µg	1150	Order
RPN1336	cDNA-Porcine reproductive and respiratory syndrome virus Non-structural protein 11 (a.a.3591 to 3813)	Q9YN02	2 µg	1110	Order
RPN1337	cDNA-Porcine reproductive and respiratory syndrome virus Non-structural protein 12 (a.a.3814 to 3966)	Q9YN02	2 µg	760	Order

Please contact us for a quote on larger sizes …

Porcine reproductive and respiratory syndrome virus cDNA and recombinant antigen

Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
Recombinant protein applications: Western Blot may be used for other applications determined by the user.
Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
Protein Activity: N/A
Protein Tag: Contains A 6x histidine tag at N-terminus.
Protein Formulation: Liquid
Source: Produced from E. coli

Porcine reproductive and respiratory syndrome (PRRS) is a viral disease affecting pigs, causing reproductive failure in breeding stock and respiratory disease in growing pigs. It is caused by the PRRS virus (PRRSV), a single-stranded RNA virus. PRRSV is considered one of the most economically significant viral diseases of swine, causing significant losses to the pig industry worldwide.

Porcine reproductive and respiratory syndrome virus (PRRSV) antigen refers to the protein components of the PRRSV that can be recognized and targeted by the immune system. Recombinant PRRSV antigens can be produced in the laboratory for use in vaccines and diagnostic tests. These antigens can help stimulate the immune system to produce a protective response against PRRSV infection.

The genome of Porcine reproductive and respiratory syndrome virus (PRRSV) is a linear, positive-sense, single-stranded RNA genome with a length of approximately 15 kb. It encodes for a single polyprotein that is processed into several functional viral proteins including the structural proteins (e.g., N, M and E) and the non-structural proteins (e.g., Nsp1 to Nsp12). The genetic diversityof PRRSV strains is driven by mutations and recombination events, leading to the emergence of new variants and subtypes.Several key proteins play important roles in the replication, pathogenesis, and immune response to PRRSV.

The major envelope glycoprotein (GP5) is the most abundant protein found on the surface of PRRSV. It is involved in viral entry into host cells and is a major target for neutralizing antibodies. Other envelope proteins, including GP2, GP3, and GP4, also play important roles in viral entry and immune evasion.

The nucleocapsid protein is a structural protein that binds to the viral RNA to form the viral nucleocapsid. It plays a key role in viral replication and is also involved in the immune response to PRRSV.

The matrix protein is a structural protein that lines the inside of the viral envelope. It plays a role in virus assembly and release, and also interacts with the nucleocapsid protein.

The N protein, or nucleocapsid-associated protein, is another structural protein that binds to the viral RNA to form the nucleocapsid. It is also involved in the regulation of viral gene expression and the modulation of host immune responses.

The envelope glycoprotein (GP2) is a membrane-bound protein that is involved in viral assembly and release. It interacts with the matrix protein and other viral proteins to facilitate virus budding.

Non-structural proteins (NSPs) are proteins that are not part of the viral particle but are encoded by the virus and play important roles in viral replication and pathogenesis. NSP3, NSP11, and NSP12 are examples of PRRSV NSPs that have been extensively studied.

Ongoing research is focused on understanding the roles of these PRRSV proteins in viral pathogenesis and the development of effective treatments and vaccines for PRRSV infections in pigs.

The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.

Bioclone

Products

Porcine reproductive and respiratory syndrome virus cDNA and Antigen

Learn More

Bioclone Inc.

Welcome to BitClone